Multiplexed expansion (MultiExM) pathology
The invention provides a method for preparing an expanded biological specimen suitable for microscopic analysis. Expanding the biological sample can be achieved by anchoring biomolecules to a polymer network and swelling, or expanding, the polymer network, thereby moving the biomolecules apart as further described below. As the biomolecules are anchored to the polymer network isotropic expansion of the polymer network retains the spatial orientation of the biomolecules resulting in an expanded, or enlarged, biological specimen.
1. A method for preparing an expandable biological specimen comprising the steps of
(a) contacting the specimen with macromolecules that will bind to biomolecules within the specimen;
(b) treating the specimen with a bifunctional crosslinker;
(c) permeating the specimen with precursors of a swellable polymer;
(d) polymerizing the precursors to form a swellable polymer within the specimen;
(e) anchoring the biomolecules to the swellable polymer; and
(f) incubating the specimen with about 20% w/v of a detergent in a buffer having a pH between about 4 and about 12, the buffer comprising about 5 mM to about 100 mM of a metal ion chelator; about 0.1% to about 1.0% of a nonionic surfactant; and 10-100 mM of an antioxidant.
2. The method of claim 1 , wherein the expandable specimen is expanded by contacting the swellable polymer with a solvent or liquid to cause the swellable polymer to swell.
3. The method of claim 1 , further comprising the step of incubating the specimen in antibodies to perform immunostaining following treatment with buffer.
4. The method of claim 3 , further comprising treating the antibody-stained specimen with detergent buffer at 70° C. for 2-4 hrs to remove antibodies for sequential multiple rounds of immunostaining for antibody multiplexing.
5. The method of claim 1 , wherein the specimen is a previously preserved clinical sample.
6. The method of claim 5 , wherein the specimen is a formalin fixed paraffin embedded (FFPE) or a hematoxylin and eosin (H&E) stained tissue sample, or a fresh frozen sample, and wherein, prior to contacting step (a), the method further comprises the steps of
(i) de-coversliping the specimen if it is mounted;
(ii) subjecting the specimen to mounting medium removal if it is mounted; and
(iii) subjecting the specimen to re-hydration if step (ii) is performed.
7. The method of claim 6 , further comprising subjecting the specimen to antigen retrieval.
8. The method of claim 1 , wherein the detergent is selected from sodium dodecyl sulfate (SDS).
9. The method of claim 1 , wherein the buffer is selected from Tris, citrate, phosphate, bicarbonate, 3-morpholinopropane-1-sulfonic acid (MOPS), borate, [tris(hydroxymethyl)methylamino]propanesulfonic acid (TAPS), bicine, Tricine, (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES), 2-[(2-Hydroxy-1,1-bis(hydroxymethyl)ethyl)amino]ethanesulfonic acid (TES), and 2-(N-morpholino)ethanesulfonic acid (MES).
10. The method of claim 1 , wherein the chelator is selected from ethylenediaminetetraacetic acid (EDTA), egtazic acid (EGTA), ethylenediamine-N,N′-bis (EDDHA), ethylenediamine-N,N′-disuccinic acid (EDDS), BAPTA, and DOTA.
11. The method of claim 1 , wherein the surfactant is selected from polyethylene glycol tert-octylphenyl ether, octylphenol decaethylene glycol ether, polyethylene glycol sorbitan monolaurate, polyoxyethylene(20)sorbitan monooleate, sorbitan, polysorbate 20, polysorbate 80, polyethylene glycol (PEG), decyl glucoside, decyl polyglucose and cocamide diethanolamine (DEA).
12. The method of claim 1 , wherein the antioxidant is selected from β-mercaptoethanol and dithiothreitol (DTT).
13. The method of claim 1 , wherein the specimen is incubated in a buffer comprising 20% wt/vol SDS, 50 mM Tris, 25 mM EDTA, 0.5% octylphenol decaethylene glycol ether, and 100 mM β-mercaptoethanol.
14. The method according to claim 1 , wherein the bifunctional crosslinker is succinimidyl ester of 6-((acryloyl)amino)hexanoic acid (AcX).
15. The method of claim 1 , wherein prior to the contacting step (a) the sample is subjected to antigen retrieval.
16. The method of claim 15 , wherein when the specimen is subjected to antigen retrieval the specimen is heated in a 20 mM sodium citrate solution at about 100° C.
17. A method of preparing an expandable biological specimen comprising the steps of
(a) treating the specimen with a bifunctional crosslinker;
(b) permeating the specimen with precursors of a swellable polymer;
(c) polymerizing the precursors to form a swellable polymer within the specimen; and
(d) incubating the specimen with about 20% w/v of a detergent in a buffer having a pH between about 4 and about 12, the buffer comprising about 5 mM to about 100 mM of a metal ion chelator; about 0.1% to about 1.0% of a nonionic surfactant; and 10-100 mM of an antioxidant.
18. The method of claim 17 , wherein the expandable specimen is expanded by contacting the swellable polymer with a solvent or liquid to cause the swellable polymer to swell.
19. The method of claim 17 , wherein the specimen is incubated in a buffer comprising 20% w/v SDS, 50 mM Tris, 25 mM EDTA, 0.5% octylphenol decaethylene glycol ether, and 100 mM β-mercaptoethanol.
20. The method of claim 17 , wherein prior to the treating step (a) the specimen is subjected antigen retrieval.
21. The method according to claim 17 , wherein the bifunctional crosslinker is succinimidyl ester of 6-((acryloyl)amino)hexanoic acid (AcX).
22. A method for expanding a swellable material-embedded biological specimen comprising:
(a) incubating the specimen with about 20% w/v of a detergent in a buffer having a pH between about 4 and about 12, the buffer comprising about 5 mM to about 100 mM of a metal ion chelator; about 0.1% to about 1.0% of a nonionic surfactant; and 10-100 mM of an antioxidant; and
(b) contacting the swellable polymer with a solvent or liquid to cause the swellable polymer to swell.
23. The method of claim 22 , wherein the specimen is incubated in a buffer comprising 20% w/v SDS, 50 mM Tris, 25 mM EDTA, 0.5% octylphenol decaethylene glycol ether, and 100 mM β-mercaptoethanol.